No Data
No Data
Express News | Saili Healthcare: Received a notice of filing a case from the China Securities Regulatory Commission due to the company's suspected illegal disclosure of information
A-share changes丨The AI medical concept is repeatedly active, and the Berry gene is linked to 3 links
Gelonghui, March 20 | Berry Genomics and Celi Medical are on the 3rd board. Runda Healthcare hit a rise or fall, while Wanda Information, Hongbo Pharmaceuticals, and Sichuang Medical Benefits followed suit. According to the news, Novo Nordisk Foundation announced a few days ago that it has reached an agreement with Nvidia to build a superAI computer called “GEFION” for the Nordic country Denmark to lead the country into the AI field. Furthermore, at its annual health event “The Check Up,” Google announced a series of new initiatives to apply artificial intelligence (AI) models to the healthcare industry.
Express News | Saili Healthcare: The company advocates value investment and will focus on the development of the main business. The company kindly invites investors to pay attention to secondary market transaction risks.
The AI medical concept continues to be strong, Saili Medical's 2-in-1
Gelonghui, March 19 | Celi Medical and Berry Genes are on the same page. Aladdin and Hongbo Pharmaceuticals rose more than 7%, while Yahong Pharmaceutical and Anbiping followed suit. According to the news, Nvidia launched 25 new microservices (NIM) based on medical scenarios at the GTC conference to help global healthcare companies improve efficiency based on generative AI.
A-share SPD concept stocks fluctuated and rose, and Hefu China went up and down in a straight line
Gelonghui, March 18 | Hefu China went up and down in a straight line. Saili Medical was previously closed, and Runda Healthcare, Guoxin Health, Kaikai Industrial, and Zhejiang Zhenyuan followed suit.
The A-share DRG concept was active at the beginning of the market, and Seli Healthcare rose or stopped
Gelonghui, March 18 | Selly Healthcare closed, and Jiahe Meikang, Weining Health, and Venture Huikang followed suit.
No Data